GL1X · GenesisL1 explorer

Research workbench

Crystal structure of motavizumab Fab bound to peptide epitope

Analyse Crystal structure of motavizumab Fab bound to peptide epitope in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3IXT
Type
protein
Length
894 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Motavizumab Fab light chain; Motavizumab Fab heavy chain; Fusion glycoprotein F1
UniProt
P03420
Ligands
ACE, NH2
Pockets
10 · best druggability 0.71

Structure

x-ray diffraction · 5 distinct chains · 8% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LMotavizumab Fab light chainprotein2115% helix, 55% strand—
HMotavizumab Fab heavy chainprotein2137% helix, 54% strand—
P, CFusion glycoprotein F1protein2475% helix, 0% strandP03420
BMotavizumab Fab light chainprotein2105% helix, 55% strand—
AMotavizumab Fab heavy chainprotein2127% helix, 54% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · 2 copies · chains P, C
  • NH2 · Amino group · ion · 2 copies · chains P, C
  • EDO · 1,2-ethanediol · additive · 3 copies · chains H, P, A, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15820.710.7970empty
21220.490.8026empty
31560.410.7423empty
41190.410.7618empty
51340.390.7421empty

Interfaces

10 interfaces between chains.

  • L–H · 1716 Ų buried · 15 hydrogen bonds · protein-protein
  • B–A · 1703 Ų buried · 14 hydrogen bonds · protein-protein
  • H–P · 501 Ų buried · 5 hydrogen bonds · protein-protein
  • A–C · 494 Ų buried · 5 hydrogen bonds · protein-protein
  • H–A · 409 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 8 disulfide, 2 covalent (disulfide, covalent ligand).

Compared structures

  • 3IXT · Crystal Structure of Motavizumab Fab Bound to Peptide Epitope · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.